Completed Bones, Joints & Muscles Digestion, Kidneys & Other Organs

Male synthetic sling versus Artificial urinary Sphincter Trial for men with urodynamic stress incontinence after prostate surgery: Evaluation by Randomised controlled trial (MASTER).

In plain English

AI plain-English summary

A man who has leaked urine every day since his prostate surgery will have a plastic mesh sling or a three-part artificial sphincter surgically implanted to try to stop it. This matters because after prostate surgery—either radical prostatectomy or transurethral resection—some men develop stress incontinence that is severe enough to require a surgical implant. Until now, there has been no robust trial comparing the two main options: the male sling, a strip of mesh that lifts and compresses the urethra, and the artificial urinary sphincter, a fluid-filled cuff that the man must learn to operate by squeezing a pump in his scrotum. Surgeons and patients lack clear evidence on which device works better and costs less. If the trial shows that the simpler sling is not worse than the more complex sphincter, men could avoid the need to learn device operation and return visits for activation. The results could change NHS surgical practice, giving clinicians a reliable basis for choosing between two devices that quietly restore continence and quality of life for thousands of men each year.

View original technical description
A pragmatic multicentre randomised controlled non-inferiority trial comparing the effectiveness of the synthetic sling (‘male sling’) with the artificial urinary sphincter (AUS) for men with urodynamic stress incontinence (USI) after prostate surgery (radical prostatectomy or transurethral resection of the prostate; TURP). Health technologies being assessed: Both interventions involve the surgical implantation of a prosthetic device designed to restore continence by specialist urological surgeons. The trial will take place within designated NHS hospitals with the appropriate expertise to implant either the male sling or the AUS. Surgical procedures and other operative variables will be standardised by using agreed protocols. The male sling is a strip of plastic mesh that is placed under the urethra through an incision under the scrotum with each end passed through the obturator foramen into the upper thigh. It is then tensioned to elevate and partially compress the urethra. It is designed to be effective immediately although maximum benefit may take a few weeks to develop. The AUS is a three-part device. A fluid filled plastic cuff is placed circumferentially around the urethra which is accessed through an incision under the scrotum. The cuff is then connected by internalised plastic tubing to firstly a fluid filled pressure-regulating balloon and secondly a small mechanical pump. The balloon is placed in the retropubic space and the pump in a sub-cutaneous pocket in the scrotum. After implantation, the device is initially deactivated with the cuff empty. The man then returns to hospital typically four to six weeks after surgery for activation. He then has to learn how to operate the device. This requires three squeezes of the control pump in the scrotum to empty the cuff and allow voiding. The cuff then automatically refills over 2-3 minutes to restore continence. Setting: All surgeons carrying out AUS or male sling implantation in the UK have agreed to take part. This encompasses 23 centres: Belfast; Birmingham, Bristol; Cambridge; Cardiff; Chichester; Edinburgh; Glasgow; Leicester; Liverpool/Southport; London (2); Manchester; Middlesbrough; Newcastle, Norwich; Oxford; Salisbury; Sheffield; Stockport; Swansea; Wakefield; and Wrexham. We are confident that the trial can recruit to target exclusively in the UK. However, the applicants have collaborations with colleagues throughout Europe, particularly in Belgium and The Netherlands and the protocol would be made available for their participation if agreed and separately funded. Target population: Men with urodynamic stress incontinence (USI) after prostate surgery (radical prostatectomy or TURP), for whom surgery is judged appropriate following discussion of options between patient and clinician. For the purposes of the trial we will define men with mild incontinence as those not requiring surgery. There is no clear threshold for defining moderate or severe incontinence and little evidence of differential benefit for either intervention according to incontinence severity. We will therefore include all men whose degree of incontinence is sufficient to require surgery, from both the patient and surgeon perspectives. Measurement of costs and outcomes: The primary outcome on which non-inferiority will be judged will be participant’s report of urinary incontinence at 12 months measured by a response indicating any loss of urine to either of the two questions: “How often do you leak urine?” and “How much urine do you leak?” in the validated ICIQ-Short Form questionnaire. Twelve months was chosen since maximum benefit of the implantation device is likely to have accrued and any harms directly related to the peri-operative period will have occurred and been resolved. The primary economic outcome will be incremental cost per quality-adjusted life-year (QALY) measured using the EQ-5D at 24 months to allow for the possible need for re-interventio

Related Research

Grants with similar aims, by meaning.

Male synthetic sling versus Artificial urinary Sphincter Trial for men with urodynamic stress incontinence after prostate surgery: Evaluation by Randomised controlled trial (MASTER) - Long term follow up
Adjustable Anchored Single-Incision Mini-Slings Versus Standard Tension-Free Mid-Urethral Slings in the Surgical Management Of Female Stress Urinary Incontinence; A Pragmatic Multicentre Non–Inferiority Randomised Controlled Trial: The SIMS Trial.
Long-Term Outcomes Of Synthetic Mid-Urethral Slings (Mesh Tapes) In Surgical Treatment Of Stress Urinary Incontinence In Women – A Long-term Follow-Up Of The SIMS RCT
Prostate Resection versus Minimally Invasive Surgery Evaluation Trial- PREMISE trial
Clarifying the management of men with recurrent urethral stricture disease: A randomised trial of open urethroplasty versus endoscopic urethrotomy (OPEN)

Original classification

Research

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.